Synthetic Biologics, formerly Adeona Pharmaceuticals, is a biotechnology company specializing in the development of synthetic DNA-based therapeutics and cutting-edge disease-modifying medicines for serious illness. The company is currently developing – or has partnered the development of – product candidates designed to treat pulmonary arterial hypertension, multiple sclerosis relapses, cognitive dysfunction in multiple sclerosis, fibromyalgia, and amyotrophic lateral sclerosis. For more information, visit the company’s Web site at www.syntheticbiologics.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: